This study examined the HIV patients' attitudes towards the practice of organ transplant between HIV patients using a cross-sectional survey design. In total, 206 patients participated with a mean age of 42 (AE8.8) years. The majority (70%) were black African and women (54%), and 83% described themselves as heterosexual. Most participants (n ¼ 171, 83%) were on treatment, and 159 (93%) had viral load less than 40 copies/ml. Mean duration of illness and mean duration of treatment were 77 (AE42.7) and 68 (AE41) months, respectively. Of all participants, 128 (62%) reported that they would consider donating either any organ or a specific organ/s to an HIV patient, 33 (16%) would not consider it and 45 (22%) were unsure about donating their organs. Furthermore, 113 (55%) participants would consider receiving an organ from an HIV patient, 37 (18%) would not consider it, and 56 (27%) were unsure. Ninety-eight participants (42%) reported that they would consider both donating and receiving an organ. Multinomial logistic regression analysis found that significantly more Black African than Caucasian participants were unsure about organ donation (p ¼ 0.011, OR ¼ 3.887). Participants with longer duration of infection were significantly less likely to consider receiving an organ from an HIV patient (p ¼ 0.036, OR ¼ 1.297). Overall, the study findings indicated that the majority of participants were in favour of organ transplant between HIV patients. Use of HIV-infected donors could potentially reduce current organ waiting list among HIV patients.
Background
In the era of highly active antiretroviral therapy (HAART), the spectrum of HIV disease has changed dramatically. 1, 2 Non-AIDS-defining illnesses are becoming more common causes of HIV-related mortalities and morbidities compared to AIDS-defining illnesses. 2, 3 Key examples of non-AIDS-defining illnesses include end-stage kidney disease (ESKD) and end-stage liver disease (ESLD), both of which have multi-factorial origins. 1, [4] [5] [6] [7] Kidney transplant and liver transplant could be an attractive proposition for patients who present with end-stage disease. [8] [9] [10] Recent results from a series of cases in the UK in which HIV patients have received organ transplants from HIVnegative donors are encouraging. 11 Transplants between HIV-positive patients however is not a current practice, significantly reducing the pool of available organs. The American federal law has recently lifted the ban on organ donation between HIV-infected individuals, a move that offers hope to thousands of HIV patients on transplant waiting lists. 12 This procedure is however yet to be performed in the US. Instead, the only country to have allowed this to happen is South Africa. Here, outcomes to date have been largely positive for the organ recipients. 13 The changing circumstances in the USA and South Africa, and tentative evidence of successful outcomes for HIV patients, may have implications for UK practice. In anticipation of a possible change in UK law in the future, the aim of this study was to explore the attitude of UK HIV patients towards organ transplant between HIV-infected patients.
Methodology
This study had a cross-sectional survey design. Over a period of three months, all HIV patients attending for a routine follow-up at an HIV outpatient clinic within a large city centre Genitourinary Medicine (GUM) department, were invited to participate. The expected clinic attendance over this period was around 300. 14 Hence, a sample size of 150 to 200 participants was aimed for, which would provide a favourably low margin of error between AE5.7% and AE4% at a confidence interval of 95%, respectively. 15, 16 This was judged to be sufficiently large to provide reasonably robust estimates of effect sizes. Participants completed a questionnaire written in simple English, with largely fixed response questions (see online supplementary material). The questions were initially developed by two GUM doctors and then piloted with 15 patients to identify their suitability and ease of comprehension. Some minor changes to the wording were made as a result. Informed consent and completion of questionnaires took place in a private room.
Participants' demographic data, including age, gender, ethnicity, sexual orientation, duration of HIV infection and both clinical and treatment history were collected. Ethical approval was obtained from a regional ethics committee. Patients were eligible to participate if they had a documented positive HIV antibody test according to the standard of HIV diagnosis, provided informed consent, and were age 18 years or over. Participants were also required to have a reasonable grasp of the English language or were alternatively able to communicate adequately with the help of an interpreter. We excluded patients with primary HIV infection, who did not consent, had poor knowledge of English and declined to use an interpreter, or were known to suffer from a mental health problem.
Responses to the questionnaires and information from the case notes were entered into SPSS (version 15.0) for analysis. Frequency analysis and multinomial logistic regression were performed.
Results

Sample description
Three hundred and eight patients attended the clinic during the study, and 206 chose to participate giving a response rate of 67%. This gave us a sampling error of 3.9%, which was within our targeted range. 15, 16 The mean age of the participants was 42 (AE8.8) years. Most reported that they were black African (n ¼ 145, 70%, CI AE 6.26) and heterosexual (n ¼ 171, 83%, CI AE 5.13). There were more women (n ¼ 111, 54%, CI AE 6.81) than men (n ¼ 95, 46%, CI AE 6.81). Mean CD4 cell count was 486 ( AE 231) cells per dl, and most participants (90%, CI AE 4.1) were on HIV treatment. Viral load was undetectable in 93% of the participants.
The main characteristics of the respondents (n ¼ 206) were similar to those who opted not to take part in the survey (non-respondents, n ¼ 102) in terms of age, gender, ethnicity, way of approach and co-morbidity ( Table 1 ).
The mean duration of illness was 77 (AE42.7) months, and the mean length of time on HAART was 68 (AE41) (Table 1 ). Seventy-one (34%, CI AE 6.47) participants had a history of opportunistic infection. One hundred and four (50%, CI AE 6.83) participants had comorbidities (Table 2) including diabetes mellitus, hypertension, impaired renal function (defined as e-GFR below 60 ml/min/1.73 m 2 at the time of the study), ischaemic heart disease, peripheral vascular disease, deranged liver function, auto-immune hepatitis, anaemia and osteoarthritis. Five participants (2%, CI AE 1.91) had a history of cancer. Twelve (6%, CI AE 3.24) participants had hepatitis B and/or C infection. Alcohol-related problems were documented in seven (3%, CI AE 2.33).
Attitude towards donating organs to HIV-infected patients
Participants were asked whether they would consider donating an organ to another HIV-infected patient. One hundred and twenty eight participants (62%, CI AE 6.63) indicated that they would donate an organ. Another 33 (16%, CI AE 5.01) indicated they would not and 45 (22%, CI AE 5.66) were not sure ( Figure 1 ). Those who would consider donating an organ to another HIV-infected patient (n ¼ 128) were asked to indicate whether this was specifically their liver, kidney, heart or other organ. Eighty-two (70%, CI AE 7.94) participants indicated they would consider donating their liver, 96 (81%, CI AE 6.80) their kidney, 75 (63%, CI AE 8.36) their heart and 17 (14%, CI AE 6.01) another type of organ. Sixty eight (58%, CI AE 8.55) participants responded that they would consider donating all three specified organs. Multinomial logistic regression was performed to examine whether there was an independent effect of any of the demographic and HIV characteristics on attitude towards organ donation. Findings indicated that an individual's attitude towards organ donation to HIV-infected patients was not associated with their age, gender, duration of infection or duration of HAART. However, there was a significant effect of ethnicity. Black African participants were more likely than Caucasian participants to indicate that they were not sure if they would consider organ donation (compared to those who would consider donation; p ¼ 0.011, OR ¼ 3.887, CI 1.36-11.08; Table 3 ). 
Attitude towards receiving an organ from HIV-infected patients
Participants were asked whether they would consider receiving an organ from an HIV-infected patient. One hundred and thirteen (55%, CI AE 6.79) participants indicated that they would, 37 (18%, CI AE 5.25) participants reported that they would not, and 56 (27%, CI AE 6.06) participants were not sure (Figure 1 ). Of the 113 participants who would consider receiving an organ, 103 participants indicated their preferred type of donor. Fourteen (14%, CI AE 6.70) participants reported that they would prefer a live donor, 6 (6%, CI AE 4.59) reported that they would prefer a deceased donor, and 83 (80%, CI AE 7.82) participants reported 'either'. Participants who reported that they would not consider receiving an organ from an HIV-infected individual were asked what their main concerns were (participants could endorse more than one response). The proportion who endorsed each response was as follows: confidentiality 26% (CI AE 14.13), infection 23% (CI AE 13.56), quality of organ 23% (CI AE 13.56) and 'other' 33% (CI AE 15.15). Multinomial logistic regression was performed to examine whether there was an independent effect of demographic and HIV characteristics on attitude towards receiving an organ. There were no variations in response for the following factors: age, gender, ethnicity or sexuality. Duration of infection, however, did have an effect, and there was a borderline effect of duration of HAART. Specifically, participants with a higher number of years of infection were more likely to indicate that they would not consider receiving an organ compared to those with a lower number of years of infection (p ¼ 0.036, OR ¼ 1.297, CI 1.02-1.61). This suggests that as the length of infection increases, HIV patients become less willing to consider accepting an organ transplant from another HIV patient. Participants with a higher number of years on HAART were more likely to indicate that they would consider receiving an organ compared to those with a lower number of years of HAART (borderline significance, p ¼ 0.052, OR ¼ 0.804, CI 0.65-1.00) ( Table 4 ).
Whether participants' motivation to accept an organ donation is to stay alive/improve quality of life
Participants were asked whether they would accept an organ to stay alive and/or improve their quality of life (QOL) (Reponses were yes, no or other). Out of the 206 participants, 135 participants (66%, CI AE 6.47) indicated that they would accept an organ transplant from an HIV-infected patient to stay alive and/or improve their QOL. Multinomial logistic regression was performed to examine the association between demographic and HIV characteristics, and responses to the above question. An individual's age, gender, ethnicity, sexuality, duration of infection or duration of HAART was not associated with whether they would accept an organ to stay alive and/or improve their QOL.
Discussion
There is a strong case for organ transplant between HIV patients to prevent unnecessary death and improve QOL. This study aimed to examine the attitude of HIV patients towards organ transplant between HIV patients, and as far as the authors are aware, this is the first study of its kind. Out of 206 participants, 62% indicated they would consider donating an organ to another HIV patient. Fifty-five per cent of participants indicated that they would consider receiving organ from HIV-infected patient. Of those who would not consider receiving a donated organ, approximately a quarter indicated that they were concerned about infection, quality of organ and confidentiality. The Euro SIDA study has shown that the death rates from HIV/AIDS have fallen eight-fold between 1994 and 2001. 17 Studies have shown that non-AIDSrelated disease, including drug-related toxicities, is becoming more common in HIV patients. 3 HIV patients may have relatively higher risk of organ failure. HIV patients with end-stage organ disease are likely to derive benefit from accepting organs from HIV-infected donors. Researchers at the Johns Hopkins University School of Medicine estimate that there are approximately 500-600 potential deceased HIV-infected kidney and liver donors per year in the US. 4 Transplants between HIV-positive patients could therefore potentially reduce or even eliminate the current waiting list for organs among HIV-positive people needing transplants and this may also shorten waiting times for non-HIV-infected patients. Muller et al. 13 have pioneered positive-to-positive kidney transplants since 2008. They have demonstrated that transplanting HIV-infected patients with ESKD with kidneys from HIV-positive donors represents a significant advance, benefiting patients with ESKD due to HIV-associated nephropathy and could be cost effective. 13 One potential concern relating to organ transplants between HIV-positive patients is the possibility of super-infection with a different HIV clade or a recombinant virus carried by a donor organ. In theory, this could accelerate HIV disease progression in the patient, particularly if that strain is resistant to antiretroviral drugs. However, some studies have suggested that in patients with well-established HIV infection on HAART, there may be a smaller number of host cells that are susceptible to the new HIV strain, hence, low risk of super/dual infection. 18 However, the HIV status of would-be donors should not be considered as disadvantage for HIV patients who are living with end organ failure. Doing so significantly restricts the pool of potential organ donors to the relatively small HIVpositive cohort.
Further trials are needed to investigate positive-topositive transplants which will yield valuable clinical insights into the functioning of HIV and the human immune system. 4 In the UK, the imbalance between donor supply and organ need is growing. In conjunction with high-quality trials to examine clinical risk, 4 there is a need for social science research to examine attitudes towards organ donation between HIV patients. This is needed to ascertain the level of support for a future HIV organ donation programme, specifically whether patients are likely to register as donors, be willing to accept an organ donation, and also whether receipt from a live or deceased donor is more acceptable. It is also needed in order to identify whether there are any particular groups who hold less favourable opinions and why. Our survey has shown that HIV patients are largely in support of both donating and receiving organs, and that the majority of patients in favour of this are happy to receive an organ from either a live or a deceased donor. A significant proportion of participants, however, indicated that they would not want to do this or were unsure. Concerns of participants who would not consider receiving an organ include confidentiality, infection and quality of organ. Further research is required to explore these concerns in more detail and to understand their basis, both for those who are against receiving an organ or unsure. This is particularly important in order to develop future patient education about organ donation between HIV patients. This study identified some potentially important associations between organ donation attitudes and demographic and HIV characteristics. Firstly, attitudes towards organ donation were associated with ethnicity. Black African participants were more likely than Caucasian participants to indicate that they would not consider donation. This may be due to cultural or religious beliefs, and further research is required to explore this. Also of interest are the findings that participants with higher number of years of infection are less likely to consider receiving an organ, but those with higher years of HAART are more likely to consider this. Reasons for these apparent inconsistent findings are unknown. Caution should be taken in drawing strong conclusions given that the relationship between years of HAART and receipt of organ was of borderline significance. Future survey research with a larger sample size is required to interrogate this. Qualitative research to further explore these beliefs would also be beneficial.
Limitations
Limitations of this study should be considered when interpreting the results. These include the fact that the patients were drawn from a single centre, and mostly of black African ethnicity. These factors reduce the external validity of the results. Furthermore, the survey design meant that there were limits to the conclusions which could be made. As discussed above, further research is required, specifically in the first instance a qualitative study, to fully explore beliefs underlying attitudes towards organ donation between HIV patients. Ideally, this would be followed by a further cross-sectional study using a larger, more representative sample and more refined questions capable of measuring the strength of these beliefs and their association with direct measures of attitude. This would enable us to better understand which beliefs are drivers of positive and negative attitudes towards organ donation, and to identify any misperceptions which could be addressed through patient education.
Conclusion
This study indicates that the attitude of HIV patients towards the practice of organ transplant between HIV patients is broadly favourable. Patients with HIV infection should have every opportunity to express their views and needs. It is suggested that an organ donation registry for patients with HIV infection is instituted and further studies conducted at a national level as outlined above. Furthermore, transplantation networks and disciplinary teams will be needed to develop ethical and clinical standards to guide medical research on positiveto-positive transplants.
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